Holi Hemp is a wholly owned subsidiary of India Globalization Capital (IGC), a publicly traded company within the cannabis & hemp space. We currently lead cannabinoid research and the development of hemp-based pharmaceuticals and wellness solutions. To date, our team has been awarded two patents and are engaged in an FDA clinical trial for the treatment of patients suffering from mild to severe dementia due to Alzheimer’s disease.

We have leveraged our clinical research to develop hemp derived products which actually deliver results. All of our formulations are championed by our Chief Scientist in conjunction with a panel of naturopathic practitioners.
All Holi Hemp products are made in our facility in Vancouver, Washington. The facility is run by our team with over 10 years of experience in the cannabis & hemp space. Our approach is quality, accuracy, and consistency. We are fully involved in and facilitate the entire production process of each of our products to ensure we deliver a high-quality, effective, and honest product.
To learn more about our patent portfolio and research, please visit: www.igcpharma.com